Zixin Pharmaceutical "recognized relatives" Sinopharm Group made an "Oolong" loss last year of more than 950 million yuan, and the annual report could not regularly disclose interface news · Securities Post date May 7, 2022 — 19:36 Post Lock Read More He Wannan: Survival of the fittest can only be achieved by retiring Post date May 7, 2022 — 13:34 Post Lock Read More The controlling shareholder of Zixin Pharmaceutical received a letter of concern from the Shenzhen Stock Exchange, requesting to explain whether Sinopharm Group and its subsidiaries can effectively control Sinopharm medicinal materials Post date May 6, 2022 — 20:19 Post Lock Read More There are 248 "non-standard" companies in the 2021 annual report, Renfu Medicine and Sunshine City are listed, and 11 "not submitted"_Shenzhen Hotline Post date May 6, 2022 — 10:10 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
He Wannan: Survival of the fittest can only be achieved by retiring Post date May 7, 2022 — 13:34 Post Lock Read More The controlling shareholder of Zixin Pharmaceutical received a letter of concern from the Shenzhen Stock Exchange, requesting to explain whether Sinopharm Group and its subsidiaries can effectively control Sinopharm medicinal materials Post date May 6, 2022 — 20:19 Post Lock Read More There are 248 "non-standard" companies in the 2021 annual report, Renfu Medicine and Sunshine City are listed, and 11 "not submitted"_Shenzhen Hotline Post date May 6, 2022 — 10:10 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The controlling shareholder of Zixin Pharmaceutical received a letter of concern from the Shenzhen Stock Exchange, requesting to explain whether Sinopharm Group and its subsidiaries can effectively control Sinopharm medicinal materials Post date May 6, 2022 — 20:19 Post Lock Read More There are 248 "non-standard" companies in the 2021 annual report, Renfu Medicine and Sunshine City are listed, and 11 "not submitted"_Shenzhen Hotline Post date May 6, 2022 — 10:10 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
There are 248 "non-standard" companies in the 2021 annual report, Renfu Medicine and Sunshine City are listed, and 11 "not submitted"_Shenzhen Hotline Post date May 6, 2022 — 10:10 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Investment hedging guide: Big bull stock BBK’s net profit in 2021 is expected to lose more than 170 million yuan, the president of China Merchants Bank was taken away for investigation, and China’s first-quarter net profit fell by 9.99% year-on-year Post date April 25, 2022 — 09:55 Post Lock Read More The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The annual report performance has changed face intensively. "Strange and precise face change" attracts regulatory attention jqknews Post date April 25, 2022 — 04:12 Post Lock Read More The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The annual report performance has changed face intensively, and the "weird and precise face change" has attracted regulatory attention jqknews Post date April 24, 2022 — 23:34 Post Lock Read More The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The annual report performance has changed face intensively, and "the strange and precise face change" has attracted regulatory attention. Post date April 24, 2022 — 20:14 Post Lock Read More Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Jilin Zixin Pharmaceutical Co., Ltd. 2021 Annual Results Announcement Amendment Post date April 23, 2022 — 10:00 Post Lock Read More Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Backgammon: Pre-loss in 2021 of 170 million to 210 million yuan; Yahua Group: Net profit in the first quarter increased by 1210% year-on-year Post date April 22, 2022 — 22:16 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zixin Pharmaceutical (002118.SZ): Haitong Asset Management, a 5.63% shareholder, plans to reduce its holdings by no more than 1%_Stock Information_Market Gold Online Post date April 22, 2022 — 21:17 Post Lock Read More Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Highlights of announcements on the evening of April 22: Wangfujing's net profit in 2021 increased by 296% year-on-year Post date April 22, 2022 — 21:16 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% Post date April 22, 2022 — 21:08 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% – yqqlm Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zixin Pharmaceutical: Haitong Asset Management plans to reduce its holdings by no more than 1% jqknews Post date April 22, 2022 — 21:07 Post Lock Read More Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zixin Pharmaceutical (002118.SZ): Haitong Asset Management has not reduced its holdings when the reduction expires_Stock Information_Market Gold Online Post date April 21, 2022 — 18:36 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:51 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:43 Post Lock Read More Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical (002118.SZ), requesting a clear explanation of the reasons for not preparing a report on changes in equity Post date April 14, 2022 — 15:40 Post Lock Read More
Caishen.CoCaishen.Co